IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma. Young JS, Cho NW, Lucas CG, Najem H, et al. Cancer Res 2026 Apr 13. doi: 10.1158/0008-5472.CAN-25-2922.

Read + Share

Amedeo Smart

Independent Medical Education

Young JS, Cho NW, Lucas CG, Najem H, et al. IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma. Cancer Res 2026 Apr 13. doi: 10.1158/0008-5472.CAN-25-2922.
PMID: 41974019